https://trialagents.com/ weekly 1.0 https://trialagents.com/reports daily 0.8 https://trialagents.com/reports?page=2 weekly 0.6 https://trialagents.com/reports?page=3 weekly 0.6 https://trialagents.com/reports?page=4 weekly 0.6 https://trialagents.com/reports?page=5 weekly 0.6 https://trialagents.com/reports?page=6 weekly 0.6 https://trialagents.com/reports/top-eu-paediatric-phase-3-trial-sites 2026-06-17T07:56:19.296Z weekly 0.7 https://trialagents.com/reports/top-eu-gastric-phase-2-and-3-trial-sites 2026-06-17T07:53:10.428Z weekly 0.7 https://trialagents.com/reports/top-eu-haematology-phase-3-trial-sites 2026-06-17T07:42:09.524Z weekly 0.7 https://trialagents.com/reports/top-eu-glioblastoma-glioma-phase-1-3-sites 2026-06-17T07:28:48.240Z weekly 0.7 https://trialagents.com/reports/top-eu-hnscc-phase-1-3-trial-sites 2026-06-17T07:26:32.551Z weekly 0.7 https://trialagents.com/reports/top-eu-heart-failure-phase-3-trial-sites 2026-06-17T07:25:49.080Z weekly 0.7 https://trialagents.com/reports/top-eu-immunology-phase-3-trial-sites 2026-06-17T07:24:26.391Z weekly 0.7 https://trialagents.com/reports/eu-infectious-disease-phase-3-sites 2026-06-17T07:23:58.586Z weekly 0.7 https://trialagents.com/reports/top-eu-ibd-phase-2-3-trial-sites 2026-06-17T07:18:41.072Z weekly 0.7 https://trialagents.com/reports/cro-use-european-breast-cancer-trials-2024-2026 2026-06-16T18:13:15.375Z weekly 0.7 https://trialagents.com/reports/cro-use-lung-cancer-trials-europe 2026-06-16T14:35:28.854Z weekly 0.7 https://trialagents.com/reports/top-cros-eu-phase-3-lung-cancer-trials 2026-06-16T12:09:11.690Z weekly 0.7 https://trialagents.com/reports/phase-3-lung-cancer-trial-design-europe 2026-06-16T10:25:23.452Z weekly 0.7 https://trialagents.com/reports/phase-3-oncology-efficacy-endpoints 2026-06-16T08:13:50.202Z weekly 0.7 https://trialagents.com/reports/efs-oncology-trials-2024-2026 2026-06-16T08:08:23.772Z weekly 0.7 https://trialagents.com/reports/adc-phase-2-3-eu-trial-sites 2026-06-15T21:15:46.594Z weekly 0.7 https://trialagents.com/reports/top-eu-nephrology-phase-2-3-sites 2026-06-15T21:08:45.680Z weekly 0.7 https://trialagents.com/reports/top-eu-ophthalmology-phase-2-3-trial-sites 2026-06-15T21:00:13.269Z weekly 0.7 https://trialagents.com/reports/top-eu-radiopharmaceutical-phase-1-3-sites 2026-06-15T20:58:49.685Z weekly 0.7 https://trialagents.com/reports/top-eu-rna-phase-1-2-trial-sites 2026-06-15T20:57:27.210Z weekly 0.7 https://trialagents.com/reports/top-eu-rna-phase-3-trial-sites 2026-06-15T20:54:38.907Z weekly 0.7 https://trialagents.com/reports/top-eu-gene-therapy-phase-1-3-sites 2026-06-15T20:48:47.018Z weekly 0.7 https://trialagents.com/reports/top-eu-vaccine-phase-1-3-trial-sites 2026-06-15T20:41:44.170Z weekly 0.7 https://trialagents.com/reports/top-eu-endometrial-cancer-trial-sites 2026-06-10T22:12:49.071Z weekly 0.7 https://trialagents.com/reports/top-eu-dermatology-phase-3-trial-sites 2026-06-10T21:03:45.196Z weekly 0.7 https://trialagents.com/reports/top-eu-depression-mdd-trial-sites-phase-2-3 2026-06-07T08:22:22.982Z weekly 0.7 https://trialagents.com/reports/top-eu-ckd-kidney-failure-trial-sites 2026-06-07T08:19:40.001Z weekly 0.7 https://trialagents.com/reports/top-european-sites-phase-i-cell-therapy-trials 2026-06-07T07:59:34.093Z weekly 0.7 https://trialagents.com/reports/top-eu-sites-cell-therapy-phase-2 2026-06-07T07:53:03.178Z weekly 0.7 https://trialagents.com/reports/top-eu-sites-phase-3-cell-therapy-trials 2026-06-07T07:38:16.060Z weekly 0.7 https://trialagents.com/reports/top-psychiatry-phase-3-eu-trial-sites 2026-06-06T12:42:23.567Z weekly 0.7 https://trialagents.com/reports/top-eu-psoriasis-psoriatic-arthritis-trial-sites 2026-06-06T12:22:13.874Z weekly 0.7 https://trialagents.com/reports/eu-bladder-urothelial-trial-active-sites 2026-06-06T11:56:08.036Z weekly 0.7 https://trialagents.com/reports/top-eu-sites-alzheimers-phase-2-3-trials 2026-06-06T11:34:10.730Z weekly 0.7 https://trialagents.com/reports/top-european-melanoma-trial-sites 2026-06-04T19:05:29.050Z weekly 0.7 https://trialagents.com/reports/top-eu-ovarian-cancer-trial-sites-phase-2-3 2026-06-04T19:03:51.778Z weekly 0.7 https://trialagents.com/reports/top-eu-ibd-trial-sites-phase-2-3 2026-06-04T18:55:33.303Z weekly 0.7 https://trialagents.com/reports/eu-upper-gi-cancer-trial-sites 2026-06-04T18:48:10.881Z weekly 0.7 https://trialagents.com/reports/top-eu-sites-prostate-cancer-phase-2-3-trials 2026-06-04T18:48:04.863Z weekly 0.7 https://trialagents.com/reports/eu-multiple-myeloma-trial-sites 2026-06-04T18:40:24.833Z weekly 0.7 https://trialagents.com/reports/top-eu-leukemia-trial-sites-phase-ii-iii 2026-06-04T18:25:47.535Z weekly 0.7 https://trialagents.com/reports/top-lymphoma-trial-sites-phase-2-3 2026-06-02T20:05:03.905Z weekly 0.7 https://trialagents.com/reports/top-colorectal-cancer-trial-sites-phase-ii-iii 2026-06-02T20:02:08.586Z weekly 0.7 https://trialagents.com/reports/top-liver-cancer-trial-sites-phase-2-3 2026-06-02T19:58:51.873Z weekly 0.7 https://trialagents.com/reports/top-kidney-cancer-trial-sites-phase-ii-iii 2026-06-02T19:45:59.651Z weekly 0.7 https://trialagents.com/reports/top-eu-diabetes-trial-sites-phase-2-3 2026-06-02T19:41:49.158Z weekly 0.7 https://trialagents.com/reports/cardiology-top-sites-patient-volume-eu 2026-06-01T21:33:21.293Z weekly 0.7 https://trialagents.com/reports/pfs-primary-endpoints-oncology-haematology-phase-iii 2026-06-01T11:16:58.417Z weekly 0.7 https://trialagents.com/reports/oncology-phase-iii-endpoint-architecture 2026-05-30T17:55:12.518Z weekly 0.7 https://trialagents.com/reports/lymphoma-phase-iii-os-vs-pfs-endpoints 2026-05-30T08:59:25.424Z weekly 0.7 https://trialagents.com/reports/os-vs-pfs-primary-endpoints-colorectal-phase-iii 2026-05-29T21:26:14.005Z weekly 0.7 https://trialagents.com/reports/kidney-cancer-os-pfs-phase-iii-trials 2026-05-29T19:41:49.798Z weekly 0.7 https://trialagents.com/reports/os-pfs-phase-iii-pancreatic-cancer-trials 2026-05-29T20:50:04.306Z weekly 0.7 https://trialagents.com/reports/how-os-pfs-used-phase-iii-oncology-trials 2026-05-29T20:56:08.970Z weekly 0.7 https://trialagents.com/reports/is-overall-survival-still-the-primary-endpoint-anchor-european-phase-iii-oncology-trials 2026-05-29T05:45:00.167Z weekly 0.7 https://trialagents.com/reports/overall-survival-primary-endpoint-phase-iii-gastric-cancer-trials 2026-05-29T05:45:11.247Z weekly 0.7 https://trialagents.com/reports/digital-recruitment-gastric-esophageal-phase-iii-trials 2026-05-29T05:45:14.721Z weekly 0.7 https://trialagents.com/reports/breast-cancer-phase-iii-endpoint-architecture-2024-2026 2026-05-29T05:45:18.418Z weekly 0.7 https://trialagents.com/reports/overall-survival-endpoint-strategy-european-phase-iii-lung-cancer-trials 2026-05-29T05:45:21.926Z weekly 0.7 https://trialagents.com/reports/digital-recruitment-channels-in-phase-iii-breast-cancer-trials 2026-05-29T11:14:07.950Z weekly 0.7 https://trialagents.com/reports/eligibility-breast-cancer-phiii 2026-05-29T11:13:43.583Z weekly 0.7